Zachary J. Sher


Zachary J. Sher


Zachary Sher is a business law associate with Foley & Lardner LLP.  He is based in the Boston office where he is a member of the Health Care Practice Group.

Prior to joining Foley, Zachary served as an associate for a New York law firm where he focused on transactional healthcare and employment law. He provided guidance regarding acquisitions, real estate, employment issues, and state and federal regulatory healthcare laws to various healthcare clients.

Representative Experience

  • Represented Sports Medicine North Orthopedic Surgery, Inc., and its affiliated ambulatory surgery center in their acquisition by Connecticut-based orthopedic and spine care management services organization Spire Orthopedic Partners, a portfolio company of Kohlberg & Co.
  • Represented Accentcare, Inc., a leading provider of home health services, in connection with a joint venture with GeissMed, a regional primary care provider platform.
21 February 2024 Deals and Wins

Foley Represents Saint Luke’s in Merger with BJC Health System

Foley & Lardner LLP represented Saint Luke’s Health System of Kansas City in its transaction with BJC Health System of St. Louis , officially combining as a single integrated, academic, patient-centric Missouri-based health system.
01 February 2024 In the News

Foley Attorneys Publish Article on New York OMIG Compliance Program Enforcement

Foley & Lardner LLP partners Jeffrey Thrope, Lawrence Vernaglia, and associate Zachary Sher authored the Compliance Today article, “NY OMIG compliance program enforcements begins, self-disclosure requirements expand.”
11 September 2023 Health Care Law Today

DTC Promotional Labeling and Advertisements: Quantitative Efficacy Wins Over FDA in Final Guidance on Presenting Risk Information

In June 2023, the U.S. Food and Drug Administration published final guidance on presenting risk and efficacy information for direct-to-consumer promotional labeling and advertisements for prescription drug and biologic products for humans and drug products for animals.
04 April 2023 Deals and Wins

Foley Represents Transcarent in Acquiring Part of 98point6 for $100M

Foley & Lardner LLP represented health and care experience company Transcarent in acquiring AI-powered virtual care platform capabilities and the care business of 98point6 in a deal worth up to $100 million.
27 April 2022 Press Releases

Foley Represents PetMed Express in Partnership with Vetster

Foley & Lardner LLP represented PetMed Express, Inc. (NASDAQ: PETS), an online pharmacy that sells prescription and non-prescription pet medication and nutritional supplements, in its partnership with Vetster, a leading veterinary telemedicine and pet-care marketplace.